Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical database.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Volumn 3, Issue 8, 2008, Pages 832-839

  Murray, Samuel ^a   Dahabreh, Issa J ^a   Linardou, Helena ^a   Manoloukos, Menelaos ^a   Bafaloukos, Dimitrios ^a   Kosmidis, Paris ^a  

^a METROPOLITAN HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ARTICLE; DRUG ANTAGONISM; FACTUAL DATABASE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MUTATION; PROGNOSIS; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DATABASES, FACTUAL; HUMANS; LUNG NEOPLASMS; MUTATION; PROGNOSIS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 52749083383     PISSN: None     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/jto.0b013e31818071f3     Document Type: Article

References (0)